CRISIL has acquired 26,22,430 equity shares or 8.90% of CARE Ratings. The company has acquired the same at a price of Rs 1659.79 per share, on June 29, 2017.
CRISIL is a global analytical company providing ratings, research and risk & policy advisory services. It rates the entire range of debt instruments: bank loans, certificates of deposit, commercial paper, non-convertible debentures, bank hybrid capital instruments, asset-backed securities, mortgage-backed securities, perpetual bonds, and partial guarantees.